SQZ Biotech

SQZ Biotech

SQZ Biotech

Intracellular delivery of macromolecules has long been a challenge in bothresearch and therapeutic applications.
Type
B2c
Founded
2013
Raised
$157M
Follow us
Twitter followers
Latest funding Show all
$65,000,000
Venture capital (Series D) - 2020
Polaris Partners Invus Temasek Holdings +4
$72,000,000
Venture capital (Series C) - 2018
Team Size
10+
Employees
$65,000,000 Venture capital (Series D)
Forbes

This MIT PhD Just Raised $65 Million For His Clinical Stage Cell Therapy Company

Xconomy , MedCity News

Roche and SQZ Biotech Expand R&D Pact in Pursuit of New Cancer Drugs

$72,000,000 Venture capital (Series C)
FinSMEs

Cell Therapy Company SQZ Biotechnologies Completes $72M Series C Financing

Funding Health Science
$4,000,000 Venture capital (Series B)
FinSMEs

SQZ Biotech Raises Further $4M in Series B Funding